“Don’t You Mean Clonazepam?” A 40-Year-Old Woman with Opioid Use Disorder Requesting Detoxification from Clonazolam (Novel/Designer Benzodiazepine) | May 21, 2020
Date of Presentation: May 21, 2020
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder ECHO Program
Keywords: #benzodiazepine #clonazolam #opioid use disorder
Dr. Ximena Levander, an Addiction Medicine & General Internal Medicine Fellow at Oregon Health & Science University, shares information to help interpret a “negative” benzodiazepine urine drug screen and determine next steps for further confirmatory testing and to recognize the emergence of novel psychoactive substances and the challenges of monitoring and reporting in a rapidly changing drug-use landscape.
Recording:
Presenter Bio:
Dr. Ximena Levander
Ximena A. Levander, MD, is an Addiction Medicine & General Internal Medicine Fellow at Oregon Health & Science University.
Resource Provided:
- “Don’t You Mean Clonazepam?” A 40-Year-Old Woman with Opioid Use Disorder Requesting Detoxification from Clonazolam (Novel/Designer Benzodiazepine) (Presentation Slides)
- Novel Psychoactive Substances
- Confidently Identify Controlled Substances/Seized Drugs Whether In or Out of Your Laboratory
Date added: May 21, 2020
